Leadership

Executive Team

Thomas B. Neff
Chairman, Founder, Chief Executive Officer

Pat Cotroneo
Vice President, Finance, and Chief Financial Officer

David M. Dimmick
Vice President, Quality

R. Wayne Frost, PharmD
Vice President, Regulatory Affairs

Al Lin, MD, PhD
Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)

Michael D. Lowenstein
Vice President, Legal Affairs

Michael Martinelli, PhD
Vice President, Technical Development

James W. Polarek, PhD
Vice President, Protein Therapeutics and Collagen Development

Leanne C. Price
Vice President, Intellectual Property

Ted Tucker
Vice President, Human Resources

Frank H. Valone, MD
Chief Medical Officer

K. Peony Yu, MD
Vice President, Clinical Development

Board of Directors

Thomas B. Neff
Chairman, Founder, Chief Executive Officer

Thomas F. Kearns Jr
Retired Partner, Bear, Stearns & Co., Inc.

Kalevi Kurkijärvi PhD
Senior Partner, Chairman and CEO, BioFund Management Fund Ltd.

Miguel Madero
Fomento Direccion, Mexico

Rory B. Riggs
Managing Member, Balfour LLC; Former President and Director, Biomatrix, Inc.

Roberto Pedro Rosenkranz, PhD, MBA
Chairman and Chief Executive Officer, ROXRO PHARMA, Inc.; Director, Pherin Pharmaceuticals

Jorma Routti, PhD
Chairman of the Board of Directors, FibroGen Europe, Former Director General of the Directorate of Science, Research and Development of the European Commission

James A. Schoeneck
President and CEO, Depomed, Inc.

Julian N. Stern
Counsel to Goodwin Procter, LLP.

Toshinari Tamura, PhD
Former Representative Director, Executive Vice President and Chief Science Officer of Astellas Pharma, Inc.